Saturday, April 04, 2015 2:08:32 PM
I picked a model that's similar to the way NFLX is valued: market cap is 5x revenue. Since growth potential is much better for HHSE than NFLX I used a range of 5-7x revenue.
A market cap valuation using a revenue multiple model produced a price band of $0.0211 - $0.0296, whereas the P/E valuation is $0.042. In either case HHSE at $0.013 is severely undervalued.
The paradox of iHub: buy high, sell low
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM